These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12501759)

  • 1. [Measurement of cytokines in patients with exercise-induced asthma treated with anti-leukotrienes].
    Flores Sandoval G; Orea Solano M; Cortés Padilla V; Santos Argumedo L
    Rev Alerg Mex; 2002; 49(5):143-8. PubMed ID: 12501759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between eosinophils, activated T lymphocyte, leukotreine and the exercise-induced asthma].
    Guo Y; Sun T; Zhang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):360-4. PubMed ID: 11802990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aspirin induced asthma, urinary leukotriene E4 and zafirlukast].
    Orea Solano M; Flores Sandoval G; Machado C F; Romero H; Santos Argumedo L
    Rev Alerg Mex; 2002; 49(2):52-6. PubMed ID: 12092526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.
    Kemp JP; Korenblat PE; Scherger JE; Minkwitz M
    J Fam Pract; 1999 Jun; 48(6):425-32. PubMed ID: 10386485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT).
    Korenblat PE; Kemp JP; Scherger JE; Minkwitz MC; Mezzanotte W
    Ann Allergy Asthma Immunol; 2000 Feb; 84(2):217-25. PubMed ID: 10719780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study to evaluate the safety and efficacy of zafirlukast ("Accolate") in patients with mild to moderate asthma in Ibadan, Nigeria.
    Ige OM; Onadeko BO
    West Afr J Med; 2001; 20(4):220-6. PubMed ID: 11885876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness.
    Dessanges JF; Préfaut C; Taytard A; Matran R; Naya I; Compagnon A; Dinh-Xuan AT
    J Allergy Clin Immunol; 1999 Dec; 104(6):1155-61. PubMed ID: 10588995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
    Pearlman DS; Ostrom NK; Bronsky EA; Bonuccelli CM; Hanby LA
    J Pediatr; 1999 Mar; 134(3):273-9. PubMed ID: 10064661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
    Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
    J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma.
    Carratù P; Morelli N; Freire AX; Pugazhenthi M; Guerra S; Umberger R; Allegra L
    Respiration; 2003; 70(3):249-53. PubMed ID: 12915743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Zafirlukast ('Accolate') in the management of patients with mild-to-moderate asthma.
    Chukwu C; Okpapi J; Ige MO; Obodo JO
    West Afr J Med; 2000; 19(2):111-9. PubMed ID: 11070746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on relationship between leukotrienes and exercise-induced asthma].
    Sun T; Guo Y; Zhang H
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):54-6. PubMed ID: 11953129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.
    Centanni S; Santus P; Casanova F; Di Marco F; Brazzola G; Canonica GW
    Drugs Exp Clin Res; 2000; 26(4):133-8. PubMed ID: 11109513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial.
    Grossman J; Smith LJ; Wilson AM; Thyrum PT
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):361-9. PubMed ID: 10227334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
    Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
    Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
    Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
    Virchow JC; Prasse A; Naya I; Summerton L; Harris A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN-gamma secretion.
    Gibbons FK; Israel E; Deykin A; Schaub B; He HZ; Perkins DL; Finn PW
    J Clin Immunol; 2005 Sep; 25(5):437-44. PubMed ID: 16160912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.